Literature DB >> 31533018

Increasing the expression level of ChR2 enhances the optogenetic excitability of cochlear neurons.

Xiankai Meng1,2, Swetha Murali3, Yen-Fu Cheng1, Jingrong Lu1, Ariel E Hight1, Vivek V Kanumuri1,2, M Christian Brown1,2, Jeffrey R Holt2,3, Daniel J Lee1,2, Albert S B Edge1,2.   

Abstract

Optogenetics comprise a promising alternative to electrical stimulation for characterization of neural circuits and for the next generation of neural prostheses. Optogenetic stimulation relies on expression of photosensitive microbial proteins in animal cells to initiate a flow of ions into the cells in response to visible light. Here, we generated a novel transgenic mouse model in which we studied the optogenetic activation of spiral ganglion neurons, the primary afferent neurons of the auditory system, and showed a strong optogenetic response, with a similar amplitude as the acoustically evoked response. A twofold increase in the level of channelrhodopsin expression significantly increased the photosensitivity at both the single cell and organismal levels but also partially compromised the native electrophysiological properties of the neurons. The importance of channelrhodopsin expression level to optogenetic stimulation, revealed by these quantitative measurements, will be significant for the characterization of neural circuitry and for the use of optogenetics in neural prostheses.NEW & NOTEWORTHY This study reveals a dose-response relationship between channelrhodopsin expression and optogenetic excitation. Both single cell and organismal responses depend on the expression level of the heterologous protein. Expression level of the opsin is thus an important variable in determining the outcome of an optogenetic experiment. These results are key to the implementation of neural prostheses based on optogenetics, such as next generation cochlear implants, which would use light to elicit a neural response to sound.

Entities:  

Keywords:  ChR2 expression level; auditory brainstem response; optogenetic stimulation; spiral ganglion neuron

Year:  2019        PMID: 31533018      PMCID: PMC6879948          DOI: 10.1152/jn.00828.2018

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  50 in total

1.  Speech recognition in noise as a function of the number of spectral channels: comparison of acoustic hearing and cochlear implants.

Authors:  L M Friesen; R V Shannon; D Baskent; X Wang
Journal:  J Acoust Soc Am       Date:  2001-08       Impact factor: 1.840

2.  Presynaptic Na+ channels: locus, development, and recovery from inactivation at a high-fidelity synapse.

Authors:  Ricardo M Leão; Christopher Kushmerick; Raphael Pinaud; Robert Renden; Geng-Lin Li; Holger Taschenberger; George Spirou; S Rock Levinson; Henrique von Gersdorff
Journal:  J Neurosci       Date:  2005-04-06       Impact factor: 6.167

3.  Requirement for Bhlhb5 in the specification of amacrine and cone bipolar subtypes in mouse retina.

Authors:  Liang Feng; Xiaoling Xie; Pushkar S Joshi; Zhiyong Yang; Koji Shibasaki; Robert L Chow; Lin Gan
Journal:  Development       Date:  2006-11-08       Impact factor: 6.868

4.  Bhlhb5 is required for the subtype development of retinal amacrine and bipolar cells in mice.

Authors:  Liang Huang; Fang Hu; Liang Feng; Xiong-Jian Luo; Guoqing Liang; Xiang-Yun Zeng; Jing-Lin Yi; Lin Gan
Journal:  Dev Dyn       Date:  2013-11-13       Impact factor: 3.780

5.  Improving speech perception in noise with current focusing in cochlear implant users.

Authors:  Arthi G Srinivasan; Monica Padilla; Robert V Shannon; David M Landsberger
Journal:  Hear Res       Date:  2013-03-01       Impact factor: 3.208

6.  Channelrhodopsin-2-XXL, a powerful optogenetic tool for low-light applications.

Authors:  Alexej Dawydow; Ronnie Gueta; Dmitrij Ljaschenko; Sybille Ullrich; Moritz Hermann; Nadine Ehmann; Shiqiang Gao; André Fiala; Tobias Langenhan; Georg Nagel; Robert J Kittel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

7.  Auditory-nerve responses to varied inter-phase gap and phase duration of the electric pulse stimulus as predictors for neuronal degeneration.

Authors:  Dyan Ramekers; Huib Versnel; Stefan B Strahl; Emma M Smeets; Sjaak F L Klis; Wilko Grolman
Journal:  J Assoc Res Otolaryngol       Date:  2014-01-28

8.  Channelrhodopsin-2, a directly light-gated cation-selective membrane channel.

Authors:  Georg Nagel; Tanjef Szellas; Wolfram Huhn; Suneel Kateriya; Nona Adeishvili; Peter Berthold; Doris Ollig; Peter Hegemann; Ernst Bamberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

9.  ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.

Authors:  John Y Lin; Per Magne Knutsen; Arnaud Muller; David Kleinfeld; Roger Y Tsien
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

Review 10.  The form and function of channelrhodopsin.

Authors:  Karl Deisseroth; Peter Hegemann
Journal:  Science       Date:  2017-09-15       Impact factor: 47.728

View more
  4 in total

1.  Functional Connectome Analysis of the Striatum with Optogenetics.

Authors:  Nao Chuhma
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.

Authors:  Chunxiu Yu; Isaac R Cassar; Jaydeep Sambangi; Warren M Grill
Journal:  J Neurosci       Date:  2020-04-20       Impact factor: 6.167

3.  Viral-mediated transduction of auditory neurons with opsins for optical and hybrid activation.

Authors:  Rachael T Richardson; Alex C Thompson; Andrew K Wise; Elise A Ajay; Niliksha Gunewardene; Stephen J O'Leary; Paul R Stoddart; James B Fallon
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

4.  Optical stimulation of neural tissue.

Authors:  Rachael Theresa Richardson; Michael R Ibbotson; Alexander C Thompson; Andrew K Wise; James B Fallon
Journal:  Healthc Technol Lett       Date:  2020-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.